We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer (REALME)

This study has suspended participant recruitment.
(Difficulty in enrolling patients)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01320501
First Posted: March 22, 2011
Last Update Posted: May 13, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
National Guard Health Affairs
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)